| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.005 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |